Clinical Trial

Iodine Status and Characteristics of Papillary Thyroid Cancer

Name: Iodine Status and Characteristics of Papillary Thyroid Cancer — clinical trial record (NCT06626581)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

The effect of iodine on papillary thyroid cancer has been controversial for many years. The investigators designed a cross-sectional study and aimed to explore the relationship between the serum and urine iodine levels and the clinical and molecular characteristics of papillary thyroid cancer.

Trial Details

NCT Number	NCT06626581
Lead Sponsor	Shandong Provincial Hospital
Conditions	Papillary Thyroid Carcinoma
Enrollment	600 participants
Start Date	2024-11-01
Primary Completion	2026-11-01 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2024-10-04